| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.1M | +3.7% |
| R&D Expense | $959K | +235.3% |
| SG&A Expense | $6.1M | +14.0% |
| Operating Income | -$5.0M | -37.1% |
| Pre-tax Income | -$3.5M | -15.4% |
| Income Tax | $0 | — |
| Net Income | -$3.5M | -15.4% |
| EPS (Basic) | -$1.11 | +8.3% |
| EPS (Diluted) | -$1.11 | +8.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.2M | +0.2% |
| Accounts Receivable | $1.0M | +79.9% |
| Current Assets | $4.6M | +9.7% |
| Total Assets | $10.0M | +4.3% |
| Current Liabilities | $900K | +24.1% |
| Stockholders' Equity | $9.1M | +2.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.3M | +23.5% |
| Financing Cash Flow | $3.3M | — |